{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:30:36Z","timestamp":1786987836637,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012332","name":"InterTradeIreland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.eclinm.2023.101984","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T07:04:30Z","timestamp":1682579070000},"page":"101984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia"],"prefix":"10.1016","volume":"59","author":[{"given":"Scott","family":"McPherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8006-807X","authenticated-orcid":false,"given":"Getinet","family":"Tafese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Tafese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinknesh Wolde","family":"Behaksra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhanu","family":"Oljira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirpa","family":"Miecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-5811","authenticated-orcid":false,"given":"Kaleab A.","family":"Debebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biruck","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teshome","family":"Gebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikreab","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikre","family":"Seife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fentahun","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belete","family":"Mammo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.W.","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Gadisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2023.101984_bib2","series-title":"Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030","first-page":"196","author":"Abela-Ridder","year":"2020"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101984_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005163","article-title":"Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa","volume":"11","author":"Fischer","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101984_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1179\/2047773211Y.0000000010","article-title":"Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria","volume":"105","author":"Evans","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"issue":"76","key":"10.1016\/j.eclinm.2023.101984_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4269\/ajtmh.2007.76.1153","article-title":"Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers","volume":"6","author":"Amsden","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"98","key":"10.1016\/j.eclinm.2023.101984_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1179\/000349804225021370","article-title":"The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus","volume":"6","author":"Awadzi","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101984_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000236","article-title":"The effect of azithromycin on ivermectin pharmacokinetics - a population pharmacokinetic model analysis","volume":"2","author":"El-Tahtawy","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101984_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002221","article-title":"A\u00a0cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali","volume":"7","author":"Coulibaly","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eclinm.2023.101984_bib9","series-title":"Zithromax\u00ae 2019 management guide: how to successfully apply for, administer, and manage the Zithromax\u00ae donation for trachoma elimination","year":"2019"},{"key":"10.1016\/j.eclinm.2023.101984_bib10","series-title":"Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures","first-page":"36","year":"2016"},{"key":"10.1016\/j.eclinm.2023.101984_bib11","series-title":"Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration","year":"2011"},{"issue":"8869","key":"10.1016\/j.eclinm.2023.101984_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0140-6736(93)91591-9","article-title":"Randomised controlled trial of single-dose azithromycin in treatment of trachoma","volume":"342","author":"Bailey","year":"1993","journal-title":"Lancet"},{"issue":"327","key":"10.1016\/j.eclinm.2023.101984_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM199209243271304","article-title":"A\u00a0controlled trial of single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis","volume":"327","author":"Martin","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.eclinm.2023.101984_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002447","article-title":"A\u00a0review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101984_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101984_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/ciy574","article-title":"Randomized trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2023.101984_bib18","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(18)30397-8","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial","volume":"6","author":"Romani","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2023.101984_bib19","series-title":"65th annual meeting of the American society of tropical medicine and hygiene","article-title":"Co-administration of drugs for NTDs: efficacy, efficiency and safety in mass drug administration programs","author":"Marks","year":"2016"},{"key":"10.1016\/j.eclinm.2023.101984_bib20","article-title":"Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial","volume":"18","author":"John","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"404","key":"10.1016\/j.eclinm.2023.101984_bib21","first-page":"1","article-title":"Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases","author":"John","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2023.101984_bib22","series-title":"Safety in administering medicines for neglected tropic diseases","year":"2021"}],"updated-by":[{"DOI":"10.1016\/j.eclinm.2023.102120","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702300161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702300161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T09:48:52Z","timestamp":1707644932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702300161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":20,"alternative-id":["S258953702300161X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101984","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101984"}}